STOCK TITAN

CTS Corp SEC Filings

CTS NYSE

Welcome to our dedicated page for CTS SEC filings (Ticker: CTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

CTS Corporation filings document operating results, Regulation FD investor materials and governance disclosures for a manufacturer of sensors, actuators and electronic components. Form 8-K reports furnish quarterly and annual earnings releases, webcast slides and investor presentations tied to the company's end-market strategy and financial outlook.

CTS regulatory filings also cover proxy governance and compensation matters, board and executive officer changes, material agreements, and financing arrangements, including an unsecured revolving credit facility. These records describe the company's capital structure, leadership, treatment of furnished materials under the Exchange Act and risk language for forward-looking statements.

Rhea-AI Summary

CTS CORP President & CEO Kieran O'Sullivan reported equity compensation activity involving company common stock. On the certification of performance for a 2023-2025 period under the 2018 Equity and Incentive Compensation Plan, he acquired 16,873 shares as earned Performance Stock Units at a reference price of $52.94 per share. To cover tax withholding obligations tied to vesting of restricted shares, 7,526 shares were surrendered, also at $52.94 per share. After these grant and tax-withholding disposition entries, his directly held stake stands at 437,693 CTS shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CTS Corporation is an Indiana-based manufacturer of sensors, connectivity components and actuators serving transportation, industrial, medical, and aerospace and defense markets worldwide. It supplies primarily OEMs, tier-one suppliers and the U.S. government, with highly engineered, application-specific products.

In 2025, CTS’ net sales mix shifted toward diversification: transportation represented 43% of consolidated net sales, industrial 26%, medical 16%, and aerospace and defense 15%. Non‑U.S. operations generated 43.7% of net sales, reflecting substantial international exposure and manufacturing in China, Mexico, Europe and Asia.

The company remains customer‑concentrated: Toyota Motor Corporation accounted for 11.2% of 2025 net sales and Cummins 8.4%. At December 31, 2025, CTS employed 3,492 people, mainly in North America and Asia, and emphasized talent development, safety, diversity and an ethics-driven culture.

CTS highlights extensive risk factors, including reliance on a few large customers, cyclical end markets, supply chain constraints, inflation, geopolitical conflicts, environmental obligations, cybersecurity threats, technology change, climate-related regulation, indebtedness covenants and global compliance requirements. As of June 30, 2025, the aggregate market value of voting and non‑voting stock held by non‑affiliates was approximately $1.24 billion, with 28,695,710 shares outstanding on February 17, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

O'SULLIVAN KIERAN M reported acquisition or exercise transactions in this Form 4 filing.

CTS Corp President & CEO Kieran M. O'Sullivan received a grant of 24,596 shares of common stock on February 12, 2026, at a price of $56.92 per share. This restricted stock award vests in equal installments over three years starting on the first anniversary of the grant date, contingent on continued service. Following this award, he beneficially owns 428,346 CTS shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Pacioni Mark R. reported acquisition or exercise transactions in this Form 4 filing.

CTS Corp’s Chief Legal and Administrative Officer, Mark R. Pacioni, received a restricted stock award of 3,693 shares of common stock on February 11, 2026, valued at $57.15 per share. The grant was made under the CTS Corporation 2018 Equity and Incentive Compensation Plan.

The restricted shares vest in equal installments over three years, beginning on the first anniversary of the grant date, and are subject to his continued service. Following this award, Pacioni beneficially owns 8,293 shares of CTS common stock, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CTS Corporation Senior Vice President Pratik Trivedi received an equity grant of 3,500 shares of common stock. The Form 4 reports this as an acquisition at a reference price of $57.15 per share, increasing his directly held stake to 11,438 shares.

The award is restricted stock granted under the CTS Corporation 2018 Equity and Incentive Compensation Plan. It vests in equal installments over three years, beginning on the first anniversary of the grant date, and is contingent on continued service with the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Agrawal Ashish reported acquisition or exercise transactions in this Form 4 filing.

CTS Corporation reported that its CFO, Ashish Agrawal, received a grant of common stock under the CTS Corporation 2018 Equity and Incentive Compensation Plan.

The award covers 6,002 shares of restricted stock at $57.15 per share. These shares vest in equal installments over three years, starting on the first anniversary of the grant date, as long as he continues in service. After this grant, Agrawal directly owns 106,744 shares of CTS common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A shareholder of CTS has filed a notice of proposed sale under Rule 144 for 13,522 shares of common stock, with an aggregate market value of $764,155.26. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/12/2026.

The filing notes that these shares were acquired through multiple restricted stock vesting events under a registered plan in exchange for services rendered. The notice also includes a representation that the seller is not aware of any undisclosed material adverse information about CTS’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
other
-
Rhea-AI Summary

Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership in CTS Corp. It reports holding 2,262,448 shares, representing 7.8% of the company’s common stock. Wasatch has sole voting power over 1,538,275 shares and sole dispositive power over all 2,262,448 shares.

The firm states the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of CTS Corp.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

CTS Corp officer Pratik Trivedi filed an amended insider trading report to correct a prior tax-withholding entry tied to vesting of restricted stock. On February 5, 2026, 125 shares of common stock were disposed of at $54.19 per share to cover tax obligations.

After this correction, Trivedi directly beneficially owns 7,938 shares of CTS common stock. The amendment states that no other changes were made beyond updating the number of shares withheld for taxes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

CTS Corp President & CEO and director Kieran M. O'Sullivan reported two insider transactions on common stock dated February 9, 2026. He disposed of a total of 6,980 shares through tax-withholding dispositions tied to restricted stock vesting, valued at $55.58 per share. According to the filing, the shares were surrendered to satisfy tax withholding obligations when restricted stock awards vested. After these transactions, he directly owned 403,750 shares of CTS common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many CTS (CTS) SEC filings are available on StockTitan?

StockTitan tracks 49 SEC filings for CTS (CTS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CTS (CTS)?

The most recent SEC filing for CTS (CTS) was filed on February 26, 2026.